Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease

Author： Priest Virginia L.   Begg Evan J.   Gardiner Sharon J.   Frampton Christopher M.A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.8, 2006-01, pp. : 767-781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is There Still a Room for Azathioprine Monotherapy in Inflammatory Bowel Disease?

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1471-1479

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

By L.P.L. Gilissen  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 479-486

Adis International

Access to resources Recommend Favorite

Recent advances in the management of inflammatory bowel disease

By Irving Peter M  

Clinical Medicine, Vol. 9, Iss. 6, 2009-12 ,pp. : 605-608

Royal College Of Physicians

Access to resources Recommend Favorite

Management of Inflammatory Bowel Disease Patients with a Cancer History

By  

Current Drug Targets, Vol. 15, Iss. 11, 2014-10 ,pp. : 1042-1048

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Dietary Polyphenols in the Management of Inflammatory Bowel Disease

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 3, 2015-01 ,pp. : 196-210

Bentham Science Publishers

Access to resources Recommend Favorite